Author:
Boige V, ,Raoul J-L,Pignon J-P,Bouché O,Blanc J-F,Dahan L,Jouve J-L,Dupouy N,Ducreux M
Publisher
Springer Science and Business Media LLC
Reference30 articles.
1. Cancer of the Liver Program (CLIP) Investigators (1998) A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients: the cancer of the liver program (CLIP) investigators. Hepatology 28: 751–755
2. Abou-Alfa GK, Schwartz L, Ricci S, Amadori D, Santoro A, Figer A, De Greve J, Douillard JY, Lathia C, Schwartz B, Taylor I, Moscovici M, Saltz LB (2006) Phase II study of sorafenib in patients with advanced hepatocellular carcinoma. J Clin Oncol 24: 4293–4300
3. Bearz A, Sorio R, Tommasi G, Toffoli G, Scarlone S, Beretta M, Frustaci S, Freschi A, Buonadonna A, Rupolo M, Tabaro G, Michieli M, Canale V, Cartei G (2001) Oxaliplatin and 5-FU in hepatocarcinoma. Proc Am Soc Clin Oncol 20: 148b (abstract 2343)
4. Borner MM, Dietrich D, Stupp R, Morant R, Honegger H, Wernli M, Herrmann R, Pestalozzi BC, Saletti P, Hanselmann S, Muller S, Brauchli P, Castiglione-Gertsch M, Goldhirsch A, Roth AD (2002) Phase II study of capecitabine and oxaliplatin in first and second-line treatment of advanced or metastatic colorectal cancer. J Clin Oncol 20: 1759–1766
5. Brienza S, Vignoud J, Itzhaki M, Krikorian A (1995) Oxaliplatin: global safety in 682 patients. Proc Am Soc Clin Oncol 14: 209 (abstract 513)
Cited by
75 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献